This inventor holds 1 USPTO granted patent. Top assignee: Merck Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Elise M Siegel: Innovator in Pharmaceutical Chemistry
Introduction
Elise M Siegel is a prominent inventor based in Jersey City, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that enhance P53 activity. Her work is crucial in the fight against diseases associated with the HDM2 protein.
Latest Patents
Elise M Siegel holds a patent for "Substituted piperidines that increase P53 activity and the uses thereof." This invention discloses novel compounds that act as inhibitors of the HDM2 protein. The patent outlines methods for preparing these compounds, as well as pharmaceutical compositions that include one or more of these compounds. The methods described aim to treat, prevent, and inhibit diseases associated with the HDM2 protein or P53.
Career Highlights
Elise is currently employed at Merck GmbH, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in the field has positioned her as a valuable asset to her team and the company.
Collaborations
Throughout her career, Elise has collaborated with notable colleagues, including Yao Ma and Brian Robert Lahue. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Elise M Siegel's work exemplifies the impact of innovation in pharmaceutical chemistry. Her contributions to enhancing P53 activity through novel compounds are paving the way for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile